Semaglutide NAION Risk: EMA Review Initiated Am...

By João L. Carapinha

January 21, 2025

The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) is reviewing the potent...
AI Tool Predicts Type 2 Diabetes Risk via ECG Up to 10 Years Early
Zepbound Outperforms Wegovy in Weight Loss Trial
Dark Chocolate: A Sweet Ally Against Type 2 Diabetes and More
Addressing Physical Inactivity in MENA and Beyond
Global Diabetes Trends and Treatment Gaps: 1990-2022 Analysis
Urgent Call for Universal Diabetes Care in Europe Amidst Political Apathy
Diabetes Diagnosis through Retinal Imaging and Deep Learning
Rising Diabetes Prevalence in the Middle East and North Africa
Diabetes Crisis in South Africa: Prevalence, Impact, and Solutions
GCC Healthcare Concerns: Key Challenges and Solutions for Residents
AI-Ready Dataset Revolutionizes Type 2 Diabetes Research
Rethinking Diabetes Strategy: The Need for a Systems Approach